Neurotoxic mechanisms of degeneration in motor neuron diseases

Drug Metabolism Reviews

Volumn 31, Issue 3, 1999, Pages 619-634

  Ludolph, Albert C ^a   Münch, Christoph ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Amyotrophic lateral sclerosis; Cu Zn SOD; Excitotoxicity; Free radicals; Motor neuron disease

Indexed keywords

3 OXALYLAMINOALANINE; COPPER ZINC SUPEROXIDE DISMUTASE; FREE RADICAL; GLUTAMATE RECEPTOR; GLUTAMIC ACID;

AMYOTROPHIC LATERAL SCLEROSIS; BRAIN MITOCHONDRION; CONFERENCE PAPER; ENZYME ACTIVITY; HUMAN; MOTOR NEURON DISEASE; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROTOXICITY; NEUROTRANSMISSION;

EXCITATORY AMINO ACID AGENTS; GLUTAMIC ACID; HUMANS; MITOCHONDRIA; MOTOR NEURON DISEASE; NEUROTOXINS; RECEPTORS, GLUTAMATE;

EID: 0344631768     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-100101938     Document Type: Conference Paper

References (75)

1. J. W. Olney and L. G. Sharpe, Brain lesions in an infant rhesus monkey treated with monsodium glutamate, Science, 166, 386-388 (1969).
2. D. W. Choi, Glutamate neurotoxicity and diseases of the nervous system, Neuron, 1, 623-634 (1987).
3. P. S. Spencer, D. N. Roy, A. C. Ludolph, J. Hugon, M. P. Dwivedi, and H. H. Schaumburg, Lathyrism: Evidence for role of the neuroexcitatory aminoacid BOAA, Lancet, ii, 1066-1067 (1986).
4. R. Rosen, T. Siddique, D. Patterson, D. A. Figlewicz, P. Sapp, A. Hentati, D. Donaldson, J. Goto, J. P. O'Regan, H.-X. Deng, Z. Rahmani, A. Krizus, D. McKenna-Yasek, A. Cayabyab, S. M. Gaston, R. Berger, R. E. Tanzi, J. Halperin, B. Herzfeldt, R. van den Berg, W.-Y. Hung, T. Bird, G. Deng, D. W. Mulder, C. Smyth, N. G. Laing, E. R. Soriano, M. A. Pericak-Vance, J. Haines, G. A. Rouleau, J. S. Gusella, H. R. Horvitz, and R. H. Brown, Jr., Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature, 362, 59-62 (1993).
5. G. Casari, M. De Fusco, S. Ciarmatori, M. Zeviani, M. Mora, P. Fernandez, G. De Michele, A. Filla, S. Cocozza, R. Marconi, A. Durr, B. Fontaine, and A. Ballabio, Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease, Cell, 93, 973-983 (1998).
6. H. V. Weal and A. M. Thomson, eds., Excitatory Amino Acids and Synaptic Transmission, Academic Press, London, 1991.
7. M. Hollmann and S. Heinemann, Cloned glutamate receptors, Annu. Rev. Neurosci., 17, 31-108 (1994).
8. 2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS, Neuron, 15, 193-204 (1995).
9. B. Sommer, M. Kohler, R. Sprengel, and P. H. Seeburg, RNA editing in brain controls a determinant of ion flow in glutamate-gated channels, Cell, 67, 11-19 (1991).
10. D. W. Choi, Ionic dependence of glutamate neurotoxicity, J. Neurosci., 7, 369-379 (1987).
11. P. Nicotera, M. Ankarcrona, E. Bonfoco, S. Orrenius, and S. A. Lipton, Neuronal necrosis and apoptosis: Two distinct events induced by exposure to glutamate or oxidative stress, Adv. Neurol., 72, 95-101 (1997).
12. D. W. Choi, Ischemia-induced neuronal apoptosis, Curr. Opin. Neurobiol., 6, 667-672 (1996).
13. N. A. Simonian and J. T. Coyle, Oxidative stress in neurodegenerative diseases, Annu. Rev. Pharmacol. Toxicol., 36, 83-106 (1996).
14. L. M. Garcia-Segura, D. Baetens, J. Roth, A. W. Norman, and L. Orci, Immunohistochemical mapping of calcium-binding protein immunoreactivity in the rat central nervous system, Brain Res., 296, 75-86 (1984).
15. P. Ince, N. Stout, P. Shaw, J. Slade, W. Hunziker, C. W. Heizmann, and K. G. Baimbridge, Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease, Neuropathol. Appl. Neurobiol., 19, 291-299 (1993).
16. M. F. Beal, Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol., 31, 119-130 (1992).
17. R. L. Albin and J. T. Greenamyre, Alternative excitotoxic hypotheses, Neurology, 42, 733-739 (1992).
18. A. C. Ludolph, M. Riepe, and K. Ullrich, Excitotoxicity, energy metabolism and neurodegeneration, J. Inherit. Metab. Dis., 16, 716-723 (1993).
19. P. S. Spencer, R. G. Allen, G. E. Kisby, and A. C. Ludolph, Excitotoxic disorders, Science, 248, 144 (1990).
20. A. C. Ludolph, J. Hugon, M. P. Dwivedi, H. H. Schaumburg, and P. S. Spencer, Studies on the aetiology and pathogenesis of motor neuron diseases. 1. Lathyrism: clinical findings in established cases, Brain, 110, 149-165 (1987).
21. P. S. Spencer, A. C. Ludolph, and G. E. Kisby, Are human neurodegenerative disorders linked to environmental chemicals with excitotoxic properties? Ann. NY Acad. Sci., 648, 154-160 (1992).
22. A. C. Ludolph and P. S. Spencer, Toxic models of upper motor neuron disease, J. Neurol. Sci., 139 (Suppl.), 53-59 (1996).
23. M. F. Beal, Mitochondria, free radicals, and neurodegeneration, Curr. Opin. Neurobiol., 6, 661-666 (1996).
24. R. Tandan, Clinical features and differential diagnosis of classical motor neuron disease, in Motor Neuron Disease (A. C. Williams, ed.), Chapman & Hall Medical, London, 1994, pp. 1-27.
25. T. M. Li, E. Alberman, and M. Swash, Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease, J. Neurol. Neurosurg. Psychiatry, 51, 778-784 (1988).
26. C. Bergeron, C. Petrunka, and L. Weyer, Copper/zinc superoxide dismutase expression in the human central nervous system. Correlation with selective neuronal vulnerability, Am. J. Pathol., 148, 273-279 (1996).
27. C. A. Pardo, Z. Xu, D. R. Borchelt, D. L. Price, S. S. Sisodia, and D. W. Cleveland, Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc. Natl. Acad. Sci. USA, 92, 954-958 (1995).
28. I. Fridovich, Superoxide radical and superoxide dismutases, Annu. Rev. Biochem., 64, 97-112 (1995).
29. M. B. Yim, P. B. Chock, and E. R. Stadtman, Enzyme function of copper, zinc superoxide dismutase as a free radical generator, J. Biol. Chem., 268, 4099-4105 (1993).
30. M. R. Borchelt, M. K. Lee, H. S. Slunt, M. Guarnieri, Z. S. Xu, P. C. Wong, R. H. Brown, D. L. Price, S. S. Sisodia, and D. W. Cleveland, Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity, Proc. Natl. Acad. Sci. USA, 91, 8292-8296 (1994).
31. L. I. Bruijn, M. K. Houseweart, S. Kato, K. L. Anderson, S. D. Anderson, E. Ohama, A. G. Reaume, R. W. Scott, and D. W. Cleveland, Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1, Science, 281, 1851-1854 (1998).
32. R. H. Brown, Superoxide dismutase in familial amyotrophic lateral sclerosis: models for gain of function, Curr. Opin. Neurobiol., 5, 841-846 (1995).
33. m for hydrogen peroxide, Proc. Natl. Acad. Sci. USA, 93, 5709-5714 (1996).
34. H. Volkel, M. Selzle, T. Walk, G. Jung, J. Link, and A. C. Ludolph, Altered dimerisation rate and aggregation of mutated copper/zinc superoxide dismutases in amyotrophic lateral sclerosis, unpublished.
35. H. X. Deng, A. Hentati, J. A. Tainer, Z. Iqbal, A. Cayabyab, W. Y. Hung, E. D. Getzoff, P. Hu, B. Herzfeldt, and R. P. Roos, Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase, Science, 261, 1047-1051 (1993).
36. M. C. Dal Canto and M. E. Gurney, Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: A model of familial amyotrophic lateral sclerosis (FALS), Brain Res., 676, 25-40 (1995).
37. G. Reaume, J. L. Elliott, E. K. Hoffman, N. W. Kowall, R. J. Ferrante, D. F. Siwek, H. M. Wilcox, D. G. Flood, M. F. Beal, R. H. Brown, R. W. Scott, and W. D. Snider, Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury, Nature Genet., 13, 43-47 (1995).
38. P. H. Tu, P. Raju, K. A. Robinson, M. E. Gurney, J. Q. Trojanowski, and V. M. Lee, Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions, Proc. Natl. Acad. Sci. USA, 93, 3155-3160 (1996).
39. C. J. Epstein, K. B. Avraham, M. Lovett, S. Smith, O. Elroy-Stein, G. Rotman, C. Bry, and Y. Groner, Transgenic mice with increased Cu/Zn-superoxide dismutase activity: Animal model of dosage effects in Down syndrome, Proc. Natl. Acad. Sci. USA, 84, 8044-8048 (1987).
40. Y. Li, T. T. Huang, E. J. Carlson, S. Melov, P. C. Ursell, J. L. Olson, L. J. Noble, M. P. Yoshimura, C. Berger, and P. H. Chan, Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase, Nature Genet., 11, 376-381 (1995).
41. M. Gurney, F. B. Cutting, P. Zhai, A. Doble, C. P. Taylor, P. K. Andrus, and E. D. Hall, Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis, Ann. Neurol., 39, 147-158 (1996).
42. A. Hottinger, E. G. Fine, M. E. Gurney, A. D. Zurn, and P. Aebischer, The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis, Eur. J. Neurosci., 9, 2548-2552 (1997).
43. J. D. Rothstein, L. Jin, M. Dykes-Hoberg, and R. W. Kuncl, Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity, Proc. Natl. Acad. Sci. USA, 90, 6591-6595 (1993).
44. C. Ikonomidou, Y. Qin Qin, J. Labruyere, and J. W. Olney, Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral sclerosis, J. Neuropathol. Exp. Neurol., 55, 211-224 (1996).
45. S. G. Carriedo, H. Z. Yin, and J. H. Weiss, Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro, J. Neurosci., 16, 4069-4079 (1996).
46. M. Morrison, W. G. M. Janssen, J. W. Gordon, and J. H. Morrison, Light and electron microscopic distribution of the AMPA receptor subunit, GluR2, in the spinal cord of control and G86R mutant superoxide dismutase transgenic mice, J. Comp. Neurol., 395, 523-534 (1998).
47. D. Feldmeyer, K. Kask, R. Brusa, H.-C. Kornau, R. Kolhekar, A. Rozov, N. Burnashev, V. Jensen, O. Hvalby, R. Sprengel, and P. H. Seeburg, Neurological dysfunction of mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B, Nature Neurosci., 2, 57-64 (1999).
48. J. Zuo, P. L. De Jager, K. A. Takahashi, W. Jiang, D. J. Linden, and N. Heintz, Neurodegeneration in Lurcher mice caused by mutation in delta2 glutamate receptor gene, Nature, 388, 769-773 (1997).
49. J. D. Rothstein, L. J. Martin, and R. W. Kuncl, Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis, N. Engl. J. Med., 326, 1464-1468 (1992).
50. J. D. Rothstein, M. Van Kammen, A. I. Levey, L. J. Martin, and R. W. Kuncl, Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis, Ann. Neurol., 38, 73-84 (1995).
51. T. Storck, S. Schulte, K. Hofmann, and W. Stoffel, Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain, Proc. Natl. Acad. Sci. USA, 89, 10,955-10,959 (1992).
52. Y. Kanai and M. A. Hediger, Primary structure and functional characterization of a high-affinity glutamate transporter, Nature, 360, 467-471 (1992).
53. G. Pines, N. C. Danbolt, M. Bjoras, Y. Zhang, A. Bendahan, L. Eide, H. Koepsell, J. Storm-Mathisen, E. Seeberg, and B. I. Kanner, Cloning and expression of a rat brain L-glutamate transporter, Nature, 360, 464-467 (1992).
54. W. A. Fairman, R. J. Vandenberg, J. L. Arriza, M. P. Kavanaugh, and S. G. Amara, An excitatory amino-acid transporter with properties of a ligand-gated chloride channel, Nature, 375, 599-604 (1995).
55. J. L. Arriza, W. A. Fairman, J. I. Wadiche, G. H. Murdoch, M. P. Kavanaugh, and S. G. Amara, Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex, J. Neurosci., 14, 5559-5569 (1994).
56. J. L. Arriza, S. Eliasof, M. P. Kavanaugh, and S. G. Amara, Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance, Proc. Natl. Acad. Sci. USA, 94, 4155-4160 (1997).
57. J. D. Rothstein, M. Dykes-Hoberg, C. A. Pardo, L. A. Bristol, L. Jin, R. W. Kuncl, Y. Kanai, M. A. Hediger, Y. Wang, J. P. Schielke, and D. F. Welty, Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate, Neuron, 16, 675-686 (1996).
58. K. Tanaka, K. Watase, T. Manabe, K. Yamada, M. Watanabe, K. Takahashi, H. Iwama, T. Nishikawa, N. Ichihara, T. Kikuchi, S. Okuyama, N. Kawashima, S. Hori, M. Takimoto, and K. Wada, Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1, Science, 276, 1699-1702 (1997).
59. E. Masliah, M. Alford, R. DeTeresa, M. Mallory, and L. Hansen, Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease, Ann. Neurol., 40, 759-766 (1996).
60. E. Masliah, J. Raber, M. Alford, M. Mallory, M. P. Mattson, D. Yang, D. Wong, and L. Mucke, Amyloid protein precursor stimulates excitatory amino acid transport. Implications for roles in neuroprotection and pathogenesis, J. Biol. Chem., 273, 12,548-12,554 (1998).
61. R. Torp, D. Lekieffre, L. M. Levy, F. M. Haug, N. C. Danbolt, B. S. Meldrum, and O. P. Ottersen, Reduced postischemic expression of a glial glutamate transporter, GLT1, in the rat hippocampus, Exp. Brain. Res., 103, 51-58 (1995).
62. T. Meyer, A. C. Ludolph, M. Morkel, C. Hagemeier, and A. Speer, Genomic organization of the human excitatory amino acid transporter gene GLT-1, NeuroReport, 8, 775-777 (1997).
63. T. Meyer, C. Munch, H. Volkel, P. Booms, and A. C. Ludolph, The EAAT2 (GLT-1) gene in motor neuron disease: Absence of mutations in amyotrophic lateral sclerosis and a point mutation in patients with hereditary spastic paraplegia, J. Neurol. Neurosurg. Psychiatry, 65, 594-596 (1998).
64. M. Aoki, C. L. Lin, J. D. Rothstein, B. A. Geller, B. A. Hosler, T. L. Munsat, H. R. Horvitz, and R. H. Brown, Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis, Ann. Neurol., 43, 645-653 (1998).
65. C. L. Lin, L. A. Bristol, L. Jin, M. Dykes-Hoberg, T. Crawford, L. Clawson, and J. D. Rothstein, Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis, Neuron, 20, 589-602 (1998).
66. T. Meyer, C. Munch, B. Knappenberger, S. Liebau, H. Volkel, and A. C. Ludolph, Alternative splicing of the glutamate transporter EAAT2 (GLT-1), Neurosci. Lett., 241, 68-70 (1998).
67. T. Meyer, C. Munch, S. Liebau, A. Fromm, B. Schwalenstocker, H. Volkel, and A. C. Ludolph, Splicing of the glutamate transporter EAAT2: A candidate gene of amyotrophic lateral sclerosis, J. Neurol. Neurosurg. Psychiatry, 65, 954 (1998).
68. M. Nagai, K. Abe, K. Okamoto, and Y. Itoyama, Identification of alternative splicing forms of GLT-1 mRNA in the spinal cord of amyotrophic lateral sclerosis patients, Neurosci. Lett., 244, 165-168 (1998).
69. T. Meyer, U. Lenk, G. Kuther, A. Weindl, A. Speer, and A. C. Ludolph, Studies of the coding region of the neuronal glutamate transporter gene in amyotrophic lateral sclerosis, Ann. Neurol., 37, 817-819 (1995).
70. C. Munch, B. Schwalenstocker, B. Knappenberger, S. Liebau, H. Volkel, A. C. Ludolph, and T. Meyer, 5́-heterogeneity of the human excitatory amino acid transporter cDNA EAAT2 (GLT-1), NeuroReport, 9, 1295-1297 (1998).
71. N. Utsunomiya-Tate, H. Endou, and Y. Kanai, Tissue specific variants of glutamate transporter GLT-1, FEBS Lett., 416, 312-316 (1997).
72. P. C. Wong, C. A. Pardo, D. R. Borchelt, M. K. Lee, N. G. Copeland, N. A. Jenkins, S. S. Sisodia, D. W. Cleveland, and D. L. Price, An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria, Neuron, 14, 1105-1116 (1995).
73. M. E. Gurney, H. Pu, A. Y. Chiu, M. C. Dal Canto, C. Y. Polchow, D. D. Alexander, J. Caliendo, A. Hentati, Y. W. Kwon, and H. X. Deng, Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation, Science, 264, 1772-1775 (1994).
74. R. J. White and I. J. Reynolds, Mitochondrial depolarization in glutamate-stimulated neurons: An early signal specific to excitotoxin exposure, J. Neurosci., 16, 5688-5697 (1996).
75. A. F. Schinder, E. C. Olson, N. C. Spitzer, and M. Montai, Mitochondrial dysfunction is a primary event in glutamate neurotoxicity, J. Neurosci., 16, 6125-6133 (1996).